New amyloidosis drugs and clinical trials update
A new class of drug may soon be available to Australian patients with significant cardiac AL amyloidosis
- Amyloidosis
- Clinical trials
A new class of drug may soon be available to Australian patients with significant cardiac AL amyloidosis
Cath felt “absolute relief” to be diagnosed with amyloidosis because she finally knew what she was dealing with.
Carole initially had minor symptoms before being diagnosed with amyloidosis.